TXMD - TherapeuticsMD's (TXMD) CEO Robert Finizio on Q3 2020 Results - Earnings Call Transcript
TherapeuticsMD, Inc. (TXMD) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Nichol Ochsner – Vice President of Investor Relations Robert Finizio – Chief Executive Officer James D’Arecca – Chief Financial Officer Dawn Halkuff – Chief Commercial Officer Mitchell Krassan – Chief Strategy and Performance Officer Conference Call Participants Nick Rubino – Stifel Carvey Leung – Cantor Fitzgerald Stacy Ku – Cowen and Company Douglas Tsao – H.C. Wainwright Dana Flanders – Guggenheim Presentation Operator Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Third Quarter 2020 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol, please go ahead. Nichol Ochsner Good morning, everyone. Thank you for joining today to discuss our third quarter financial results and business update. This morning, TherapeuticsMD issued a press release,
For further details see:
TherapeuticsMD's (TXMD) CEO Robert Finizio on Q3 2020 Results - Earnings Call Transcript